Heart Surgery

Latest Issue of OR Manager
November 2025
Home Surgery/Specialties > Heart Surgery

Vanderbilt heart transplant program reaches new record

Editor's Note Nashville's Vanderbilt University Medical Center (VUMC) performed a record number of heart transplants in 2017, making it the second-busiest heart transplant program in the country. VUMC performed a record 97 heart transplantations,  including pediatric cases, which surpassed the 2016 milestone of 92. Vanderbilt is building a program that…

Read More

By: Judy Mathias
February 7, 2018
Share

New clinical practice guidelines address anticoagulation during cardiopulmonary bypass

Editor's Note The Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology on January 19 announced the release of new clinical practice guidelines on the use of anticoagulants during cardiopulmonary bypass (CPB). Among the guideline recommendations are: optimal heparin dosing for initiation and maintenance…

Read More

By: Judy Mathias
January 23, 2018
Share

FDA: Class I recall of Certitude Delivery System

Editor's Note The Food and Drug Administration (FDA) on January 11 classified the recall by Edwards LifeSciences (Irvine, California) of its Certitude Delivery System as Class I, the most serious. The system is used for delivery of the Edwards SAPIEN 3 transcatheter aortic heart valve. The recall was issued because…

Read More

By: Judy Mathias
January 12, 2018
Share

Perioperative myocardial injury common after noncardiac surgery

Editor's Note Perioperative myocardial injury (PMI) is a common complication after noncardiac surgery (occurring in 1 of 7 patients), and it is associated with substantial short- and long-term mortality (9% and 22%), this study finds. This analysis included 2,018 patients having 2,546 surgical procedures. PMI occurred after 397 of the…

Read More

By: Judy Mathias
December 12, 2017
Share

Sponsored Message

Postop outcomes in OSA patients having cardiac surgery

Editor's Note Obstructive sleep apnea (OSA) is an important risk factor for postoperative complications in cardiac surgery patients, finds this meta-analysis led by Frances Chung, MD, a noted expert on OSA. After cardiac surgery, major adverse cardiac or cerebrovascular events and newly documented postoperative atrial fibrillation were 33.3% and 18.1%…

Read More

By: Judy Mathias
December 7, 2017
Share

CMS finalizes changes to bundled-payment models

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on November 30 announced a final rule that cancels the mandatory hip fracture and cardiac bundled-payment models, which were to begin on January 1, 2018, and implements changes to the Comprehensive Care for Joint Replacement (CJR) Model. In the final…

Read More

By: Judy Mathias
November 30, 2017
Share

Sponsored Message

Study: Restrictive vs liberal blood transfusion outcomes in cardiac surgery patients

Editor's Note A restrictive blood transfusion strategy (HGB <7.5 g/dL) was equivalent to a liberal strategy (HGB <9.5 g/dL in the OR or ICU and HGB<8.5 g/dL in the non-ICU ward) with regard to mortality and major disability in cardiac surgery patients who had a moderate-to-high risk of death, this…

Read More

By: Judy Mathias
November 16, 2017
Share

Periop nurses key in reducing readmissions after CABG surgery

Editor's Note Perioperative nurses engaging in patient and community education to explain coronary artery bypass grafting (CABG) surgery, reinforcing recommended discharge guidelines, and serving as expert resources are key to positive outcomes and reducing readmissions, finds this review article. In 2016, the Centers for Medicare & Medicaid Services reduced payments…

Read More

By: Judy Mathias
November 6, 2017
Share

FDA: Increased rate of major adverse events with Absorb GT1 Bioresorbable Vascular Scaffold

Editor's Note The Food and Drug Administration (FDA) on October 31 issued a Safety Alert saying that interim study results continue to show an increased rate of major adverse cardiac events and Bioresorbable Vascular Scaffold (BVS) thrombosis in patients receiving the Absorb GT1 BVS by Abbott Vascular (Abbott Park, Illinois),…

Read More

By: Judy Mathias
October 31, 2017
Share

FDA updates Safety Alert for St Jude defibrillators

Editor's Note The Food and Drug Administration (FDA) on October 19 issued an updated Safety Alert for implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators by St Jude Medical. Because batteries for the devices may fail earlier than expected, St Jude has made available a new battery performance management tool,…

Read More

By: Judy Mathias
October 23, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat